NMD4C Hosts 2nd Annual Basic Research Summer School at York University!
On May 7–8, 2025, the NMD4C preclinical research team, led by Dr. Christopher Perry, hosted the second annual Basic Research Summer School at York University. This national training event brought together 30 graduate students and postdoctoral fellows from across Canada for an intensive two-day program dedicated to advancing neuromuscular research skills and connections.
The Summer School kicked off with trainee flash talks, followed by lectures featuring patient partners, early-career and senior scientists, and members of industry. An evening networking dinner and career panel capped off the first day, offering insight into diverse research paths.
On Day 2, trainees participated in one of two full-day workshops: Myofibre Isolation and Analysis led by Dr. Anthony Scimè, or Rodent Muscle Function Assessment led by Dr. Arthur Cheng. These sessions provided rare, hands-on exposure to specialized wet lab techniques. The day concluded with an informal networking dinner to build community and spark collaboration.
Following the Summer School, many participants remained at York University to attend and present posters at Muscle Health Awareness Day —an exciting opportunity to connect with a broader community of muscle researchers.
This event would not have been possible without the tireless efforts of our organizing team: Dr. Christopher Perry (Chair), Dr. Anthony Scimè, Dr. Arthur Cheng, Adam Charnaw, Linda Niksic, Dr. Emma Sutton, Dr. Marine Christin, Dr. Erin Beattie, and James Davis.
We are grateful to our speakers and panelists, volunteers, and workshop instructors, and we extend our sincere thanks to our sponsors: The Stem Cell Network, Aurora Scientific Inc., Kent Scientific Corporation, and York University’s Vice-President Research & Innovation Office. Special thanks also go to our event photographer, Cheryl Corson.
Looking ahead, we’re thrilled to announce that next summer’s Summer School will be held in Ottawa. Stay tuned to our event webpage for updates!
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.